SGLT2 Inhibitors for Type 2 Diabetes

Annual Reports in Medicinal Chemistry

Volumn 46, Issue , 2011, Pages 103-115

  Liu, Jiwen Jim ^a   Lee, TaeWeon ^a  

^a AMGEN INC   (United States)

Author keywords

Glucosuria; Insulin independent therapy; Renal glucose reabsorption; Sodium glucose cotransporter 2; Type 2 diabetes; Urinary glucose excretion

Indexed keywords

EID: 80054100981     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386009-5.00020-5     Document Type: Chapter

References (61)

1. Abdul-Ghani M.A., DeFronzo R.A. Endocr. Pract. 2008, 14:782.
2. Centers for Disease Control, National Diabetes Fact Sheet, United States 2011, (accessed April 13, 2011). http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
3. DeFronzo R.A. Diabetes 2009, 58:773.
4. Wright E.M., Loo D.D.F., Hirayama B.A., Turk E. Physiology 2004, 19:370.
5. Vollon V., Platt K.A., Cunard R., Schroth J., Whaley J., Thomson S.C., Koepsell H., Rieg T. J. Am. Soc. Nephrol. 2010, 21:2059.
6. Scholl-Burgi S., Santer R., Ehrich J.H.H. Nephrol. Dial. Transplant. 2004, 19:2394.
7. Santer R., Calado J. Clin. J. Am. Nephrol. 2010, 5:133.
8. Morris R.C., Ives H.E. The Kidney 1996, Saunders, Philadelphia, PA, p. 1764. B.M. Brenner (Ed.).
9. Wright E.M. Am. J. Physiol. Renal Physiol. 2001, 290:F10.
10. Washburn W.N. J. Med. Chem. 2009, 52:1785.
11. Koffler M., Imamura T., Santeosanio F., Helderman J.H. Diabetologia 1988, 31:228.
12. Rossetti L., Smith D., Shulman G.I., Papachristou D., DeFronzo R.A. J. Clin. Invest. 1987, 79:1510.
13. Wright E.M., Turk E., Martin M.G. Cell Biochem. Biophys. 2002, 36:115.
14. Washburn W.N. Expert Opin. Ther. Patents 2009, 19:1485.
15. Meng W., Ellsworth B.A., Nirschl A.A., McCann P.J., Patel M., Girotra R.N., Wu G., Sher P.M., Morrison E.P., Biller S.A., Zahler R., Deshpande P.P., Pullockaran A., Hagan D.L., Morgan N., Taylor J.R., Obermeier M.T., Humphreys W.G., Khanna A., Discenza L., Robertson J.G., Wang A., Han S., Wetterau J.R., Janovitz E.B., Flint O.P., Whaley J.M., Washburn W.N. J. Med. Chem. 2008, 51:1145.
16. Kipnes M.S. Clin. Invest. 2011, 1:145-156.
17. Nomura S., Sakamaki S., Hongu M., Kawanishi E., Koga Y., Sakamoto T., Yamamoto Y., Ueta K., Kimata H., Nakayama K., Tsuda-Tsukimoto M. J. Med. Chem. 2010, 53:6355.
18. Clinical trials.gov,; Phase III studies: NCT01106690, NCT01064414, NCT01137812, NCT01081834, NCT01106625, NCT01106677, NCT01106651, NCT01032629, NCT00968812 (accessed April 14, 2011). http://clinicaltrials.gov/ct2/results?term=canagliflozin.
19. Grempler R., Thomas L., Eckhardt M., Himmels-Bach F., Sauer A., Mark M., Eikelmann P. 2009.
20. Clinical trials.gov, Phase III studies: NCT01289990, NCT01177813, NCT01164501, NCT01210001, NCT01306214, NCT01131676, NCT01159600, NCT01167881, NCT01257334 (accessed April 14, 2011). http://www.clinicaltrials.gov/ct2/results?term=BI10773.
21. Kurosaki E., Tahara A., Yokono M., Yamajuku D., Takasu T., Imamura M., Funatsu T., Li Q. 2010.
22. Schwartz S., Klasen S., Kowalski D., Akinlade B. 2010.
23. Sato T., Nishimoto M., Taka N., Ohtake Y., Takano K., Yamamoto K., Ohmori M., Yamaguchi M., Takami K., Yeu S., Ahn K., Matsuoka H., Suzuki M., Hagita H., Ozawa K., Yamaguchi K., Kato M., Ikeda S. 2010.
24. S. Ikeda, Chugai Pharmaceutics R&D conference, December 2009, (accessed April 13, 2011). http://www.chugai-pharm.co.jp/html/meeting/pdf/091207eR&D.pdf.
25. Clinical trials.gov. Study NCT01096667, (accessed April 13, 2011). http://www.clinicaltrials.gov/ct2/show/NCT01096667?term=NCT01096667&rank=1.
26. D. Powell, Endocrine Society Annual Meeting 2010 Oral presentation OR24-6, San Diego, California, (accessed April 18, 2011). http://www.lexicon-genetics.com/lexpha5/images/pdfs/LX4211_ENDO2010_Presentation.pdf.
27. Kakinuma H., Oi T., Hashimoto-Tsuchiya Y., Arai M., Kawakita Y., Fukasawa Y., Iida I., Hagima N., Takeuchi H., Chino Y., Asami J., Okumura-Kitajima L., Io F., Yamamoto D., Miyata N., Takahashi T., Uchida S., Yamamoto K. J. Med. Chem. 2010, 53:3247.
28. Thomson Reuters Integrity (accessed April 13, 2011). https://integrity.thomson-pharma.com/integrity/xmlxsl/pk_qcksrch.show_records?sessionID=1&history=&query=tofogliflozin&abbreviation=PRO&language=en.
29. Thomson Reuters Integrity (accessed April 13, 2011). https://integrity.thomson-pharma.com/integrity/xmlxsl/pk_qcksrch.show_records?sessionID=1&history=&query=asp%201941&abbreviation=PRO&language=en.
30. Ferrannini E., Tang W., Ramos S.J., List J.F., Salsali A. Diabetes Care 2010, 33:2217.
31. Pfister M., Whaley J.M., Zhang L., List J.F. Clin. Pharmacol. Ther. 2011, 89:621.
32. Zhang W., Welihinda A., Mechanic J., Ding H., Zhu L., Lu Y., Deng Z., Sheng Z., Lv B., Chen Y., Robergeb J.Y., Seed B., Wang Y. Pharamcol. Res. 2011, 63:284.
33. Kim M.J., Lee J., Kang S.Y., Lee S.H., Son E.J., Jung M.E., Lee S.H., Song K.S., Lee M., Han H.K., Kim J., Lee J. Bioorg. Med. Chem. Lett. 2010, 20:3420.
34. Lee J., Kim J.Y., Choi J., Lee S.H., Kim J., Lee J. Bioorg. Med. Chem. Lett. 2010, 20:7046.
35. Kang S.Y., Song K.S., Lee J., Lee S.H., Lee J. Bioorg. Med. Chem. 2010, 18:6089.
36. Song K.S., Lee S.H., Kim M.J., Seo H.J., Lee J., Lee S.H., Jung M.E., Son E.J., Lee M., Kim J., Lee J. ACS Med. Chem. Lett. 2011, 2:182.
37. Lee J., Lee S.H., Seo H.J., Son E.J., Lee S.H., Jung M.E., Lee M., Han H.K., Kim J., Kan J., Lee J. Bioorg. Med. Chem. 2010, 18:2178.
38. Xu B., Feng Y., Lv B., Xu G., Zhang L., Du J., Peng K., Xu M., Dong J., Zhang W., Zhang T., Zhu L., Ding H., Sheng Z., Welihinda A., Seed B., Chen Y. Bioorg. Med. Chem. 2010, 18:4422.
39. Xu B., Lv B., Feng Y., Xu G., Du J., Welihinda A., Sheng Z., Seed B., Chen Y. Bioorg. Med. Chem. Lett. 2009, 19:5632.
40. Lv B., Xu B., Feng Y., Peng K., Xu G., Du J., Zhang L., Zhang W., Zhang T., Zhu L., Ding H., Sheng Z., Welihinda A., Seed B., Chen Y. Bioorg. Med. Chem. Lett. 2009, 19:6877.
41. Lv B., Feng Y., Dong J., Xu M., Xu B., Zhang W., Sheng Z., Welihinda A., Seed B., Chen Y. ChemMedChem 2010, 5:827.
42. Yao C.H., Song J.S., Chen C.T., Yeh T.K., Hung M.S., Chang C.C., Liu Y.W., Yuan M.C., Hsieh C.J., Huang C.Y., Wang M.H., Chiu C.H., Hsieh T.C., Wu S.H., Hsiao W.C., Chu K.F., Tsai C.H., Chao Y.S., Lee J.C. J. Med. Chem. 2011, 54:166.
43. Zhou H., Danger D.P., Dock S.T., Hawley L., Roller S.G., Smith C.D., Handlon A.L. ACS Med. Chem. Lett. 2010, 1:19.
44. Park E.J., Kong Y., Lee J.S., Lee S.H., Lee J. Bioorg. Med. Chem. Lett. 2011, 21:742.
45. Robinson R.P., Mascitti V., Boustany-Kari C.M., Carr C.L., Foley P.M., Kimoto E., Leininger M.T., Lowe A., Klenotic M.K., MacDonald J.I., Maguire R.J., Masterson V.M., Maurer T.S., Miao Z., Patel J.D., Preville C., Reese M.R., She L., Steppan C.M., Thuma B.A., Zhu T. Bioorg. Med. Chem. Lett. 2010, 20:1569.
46. Goodwin N.C., Mabon R., Harrison B.A., Shadoan M.K., Almstead Z.Y., Xie Y., Healy J., Buhring L.M., DaCosta C.M., Bardenhagen J., Mseeh F., Liu Q., Nouraldeen A., Wilson A.G., Kimball S.D., Powell D.R., Rawlins D.B. J. Med. Chem. 2009, 52:6201.
47. Mascitti V., Preville C. Org. Lett. 2010, 12:2940.
48. Mederski W., Beier N., Cezanne B., Gericke R., Klein M., Tsaklakidis C. Patent Application WO2007/147478-A1 2007.
49. Klein M., Gericke R., Beier N., Cezanne B., Tsaklakidis C., Mederski W. Patent Application WO2008/046497-A1 2008.
50. Mederski W., Beier N., Burgdorf L.T., Gericke R., Klein M., Tsaklakidis C. Patent Application WO2008/ 071288-A1 2008.
51. Burgdorf L.T., Cezanne B., Klein M., Gericke R., Tsaklakidis C., Mederski W., Beier N. Patent Application WO2008/101586-A1 2008.
52. Klein M., Mederski W., Tsaklakidis C., Beier N. Patent Application WO2009/049731-A1 2009.
53. Li A., Zhang J., Greenberg J., Lee T., Liu J. Bioorg. Med. Chem. Lett. 2011, 21:2472.
54. Du X., Lizarzaburu M., Turcotte S., Lee T., Greenberg J., Shan B., Fan P., Ling Y., Medina J., Houze J. Bioorg. Med. Chem. Lett. 2011, 21. 10.1016/j.bmcl.2011.04.053.
55. Lansdell M.I., Burring D.J., Hepworth D., Strawbridge M., Graham E., Guyot T., Betson M.S., Hart J.D. Bioorg. Med. Chem. Lett. 2008, 18:4944.
56. Komoroski B., Vachharajani N., Boulton D., Kornhauser D., Geraldes M., Li L., Pfister M. Clin. Pharmacol. Ther. 2009, 85:520.
57. Port A., Macha S., Seman L., Nehmiz G., Simons G., Koegel A., Harder D., Ren B., Iovino M., Pinnetti S., Dugi K. 2010.
58. Dugi K., Mark M. 2008, /content/. /slides_mark_dugi.pdf (accessed April 16, 2011). http://www.boehringer-ingelheim.com.
59. Obermeier M., Yao M., Khanna A., Koplowitz B., Zhu M., Li W., Komoroski B., Kasichayanula S., Discenza L., Washburn W., Meng W., Ellsworth B.A., Whaley J.M., Humphreys W.G. Drug Metab Dispos. 2010, 38:405.
60. Feng B., LaPerle J.L., Chang G., Varma M. Expert Opin. Drug Metab. Toxicol. 2010, 6:939.
61. Li M., Anderson G.D., Wang J. Expert Opin. Drug Metab. Toxicol. 2006, 2:505.